Daily Management Review

Bayer's net loss shrinks 67-fold since the start of the year


German chemical-pharmaceutical concern Bayer AG posted a net loss of €161 million for the three quarters of 2021, compared with a loss of €10.803 billion a year earlier, the company said.

Sebastian Rittau
Sebastian Rittau
The loss per share amounted to €0.16 versus €11 a year earlier. Revenue rose 4.96% to €32.963 billion.

The company posted a net profit of €85 million in the third quarter compared to a loss of €2.744 billion in the same period in 2020. Earnings per share were €0.09 compared to a loss of €2.79 a year earlier. Revenue rose by 15% to €9.781 billion.

Revenues in Bayer's Pharmaceuticals division rose by 4.9% to €13.398 billion in the first nine months, the Consumer Health (OTC) division by 2.2% to €3.888 billion and the Agriculture division by 5.8% to €15.517 billion.

The company also confirmed its forecast for the year. Bayer expects revenues for the year to be in the range of €43-44 billion.

Founded in 1863, Bayer AG operates in over 300 countries with a portfolio of about 5,000 products in the fields of healthcare, crop protection and high-tech materials.

source: bloomberg.com